Literature DB >> 6092850

Expression in Bacillus subtilis of the gene for human urogastrone using synthetic ribosome binding sites.

J I Flock, I Fotheringham, J Light, L Bell, R Derbyshire.   

Abstract

A chemically synthesised gene coding for human urogastrone which was earlier cloned in E. coli (Smith et al. 1982) has now been cloned into expression vectors for Bacillus subtilis. Two types of constructs have been made, one giving production of methionyl-urogastrone and the other giving rise to a methionyl-urogastrone-beta galactosidase fusion polypeptide facilitating quantification of expression levels. The ribosome binding sites used in the expression plasmids are synthetically made oligonucleotides residing on short restriction fragments to allow easy replacement by other ribosome binding sites. Using "shuttle" vectors and constitutive promoters from Bacillus phages phi 105 and SPP1, we were able to detect levels of expression amounting to a few thousand molecules per cell during logarithmic growth in both E. coli and B. subtilis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092850     DOI: 10.1007/bf00332754

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  22 in total

1.  The relationship between molecular structure and transformation efficiency of some S. aureus plasmids isolated from B. subtilis.

Authors:  U Canosi; G Morelli; T A Trautner
Journal:  Mol Gen Genet       Date:  1978-11-09

2.  Transformation in Bacillus subtilis. Fate of newly introduced transforming DNA.

Authors:  F Arwert; G Venema
Journal:  Mol Gen Genet       Date:  1973

3.  Production in B. subtilis of hepatitis B core antigen and a major antigen of foot and mouth disease virus.

Authors:  K Hardy; S Stahl; H Küpper
Journal:  Nature       Date:  1981-10-08       Impact factor: 49.962

4.  Cascades of Sigma factors.

Authors:  R Losick; J Pero
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

5.  Analysis of gene control signals by DNA fusion and cloning in Escherichia coli.

Authors:  M J Casadaban; S N Cohen
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

6.  Escherichia coli plasmid vectors containing synthetic translational initiation sequences and ribosome binding sites fused with the lacZ gene.

Authors:  D Y Thomas; G Dubuc; S Narang
Journal:  Gene       Date:  1982-09       Impact factor: 3.688

7.  Characterization of Staphylococcus aureus plasmids introduced by transformation into Bacillus subtilis.

Authors:  T J Gryczan; S Contente; D Dubnau
Journal:  J Bacteriol       Date:  1978-04       Impact factor: 3.490

8.  Transcription after bacteriophage SPP1 infection in Bacillus subtilis.

Authors:  G Milanesi; G Cassani
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

9.  Nucleotide sequence of a Bacillus subtilis promoter recognized by Bacillus subtilis RNA polymerase containing sigma 37.

Authors:  C P Moran; N Lang; R Losick
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

10.  Expression of Escherichia coli trp genes and the mouse dihydrofolate reductase gene cloned in Bacillus subtilis.

Authors:  D M Williams; R G Schoner; E J Duvall; L H Preis; P S Lovett
Journal:  Gene       Date:  1981-12       Impact factor: 3.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.